Biome Australia (ASX:BIO) Valuation Rank


ASX:BIO Biome Australia Ltd ASX:BIO
35 GF Score
Price A$0.29
GF Value A$0.70
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Biome Australia Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Biome Australia Valuation Rank Related Terms

ASX:BIO
35GF Score
Biome Australia Ltd ASX:BIO
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biome Australia (ASX:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biome Australia stock appears to be undervalued. The current stock price of A$0.29 is trading 59.3% below its estimated GF Value™ of A$0.70. GuruFocus considers Biome Australia to be Possible Value Trap.

Key valuation signals for ASX:BIO:

  • Valuation Rank:
  • GF Value™: A$0.70 vs. price of A$0.29 (59.3% below fair value)
  • GF Score™: 35/100 with 5 warning signs

No single metric tells the full story. See the ASX:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biome Australia Business Description

Address 192-194 Johnston Street, Collingwood, VIC, AUS, 3066
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
35GF Score

Get the complete analysis for ASX:BIO

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.29
Price
A$0.70
GF Value